pharma · Obesity · Type 2 diabetes
NovoThirteen
NovoThirteen clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Bagsværd, JP HQ
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Bagsværd, JP
- Programs
- 94
- Drugs
- 67
- Patents
- 0
NovoThirteen projects
3 ClinicalTrials.gov programs sponsored by NovoThirteen.
NovoThirteen has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does NovoThirteen have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.